Nr5a2 amplification, observed in lung cancer tissues (Figure 1, 2, 3, 4, 5, 6A‐B), is associated with poor OS and PFS (Figure 1, 2, 3, 4, 5, 6C ‐D). This evidence concerns the gene NR5A2 and lung carcinoma.